Decreased plasma iron in Alzheimer's disease is due to transferrin desaturation.
about
Blood-Based Proteomic Biomarkers of Alzheimer's Disease PathologyStandards for Quantitative Metalloproteomic Analysis Using Size Exclusion ICP-MSTargeting iron metabolism in drug discovery and deliveryDirect in vivo imaging of ferrous iron dyshomeostasis in ageing Caenorhabditis elegans.Viscoelastic and ultrastructural characteristics of whole blood and plasma in Alzheimer-type dementia, and the possible role of bacterial lipopolysaccharides (LPS)Metalloneurochemistry and the Pierian Spring: 'Shallow Draughts Intoxicate the Brain'.Serum Hepcidin Levels, Iron Dyshomeostasis and Cognitive Loss in Alzheimer's Disease.Preliminary Data on the Interaction between Some Biometals and Oxidative Stress Status in Mild Cognitive Impairment and Alzheimer's Disease Patients.Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics.Interleukin-1β (IL-1β) transcriptionally activates hepcidin by inducing CCAAT enhancer-binding protein δ (C/EBPδ) expression in hepatocytes.On the outside looking in: redefining the role of analytical chemistry in the biosciences.Protein Labelling with Versatile Phosphorescent Metal Complexes for Live Cell Luminescence Imaging.Elevated plasma ferritin in elderly individuals with high neocortical amyloid-β load.Multiplexing Biomarker Methods, Proteomics and Considerations for Alzheimer's Disease.No Genetic Overlap Between Circulating Iron Levels and Alzheimer's Disease.Hepcidin: a real-time biomarker of iron need.Profiling changes to natively-bound metals during Caenorhabditis elegans development.Systemic Inflammation Is Associated With Longitudinal Changes in Cognitive Performance Among Urban AdultsSpectrometric-based techniques for metal-binding protein assessment in clinical, environmental, and food samples
P2860
Q26774743-EB202D42-E540-407B-B4B3-E7ABEFBA7035Q28830436-8E06DE01-F4DB-4620-AC24-4C081B648535Q33757232-7D8DA293-71C3-4A4B-A5EE-2A34035CECC6Q33850581-3925B3D8-59C0-4D74-A3CB-66FBB0CB71F8Q36546334-E612DDC3-46FF-44D3-B791-9DB65116B966Q37634339-0DF0A66F-3E81-4468-8ABE-066C4A3C0593Q37716145-C8ED9429-524E-405B-93A8-71036689023BQ38622838-6AA171D6-8472-4845-90B7-BAF3B3742821Q38627193-61783FF5-C956-4770-9406-E80B6BC7CE2CQ38706264-016D2F8C-E61B-457C-A4F7-AE0A48D15908Q38742529-A6DDB516-AD0C-4D0E-A4D9-F577D4CD781CQ38844451-C12B2F20-A2FE-4589-BD6C-5B4B8957BC3DQ40139851-C34D28A0-7907-4569-B799-8C87F25720CDQ47407570-F796F54C-3ECF-47E1-B1B4-C9753044C94BQ47703297-3898F6C8-7618-427E-B66F-6A7EC47A4948Q47732977-0163AECF-7672-4015-9716-37225BD76825Q50542077-AE4FA8D0-3F7B-4614-82CE-2C42C73B1818Q57816573-D72D700C-84D7-402D-9BD1-62709F3AA3EBQ58389058-F5414674-4B8A-459D-9807-C3172BAB19F3
P2860
Decreased plasma iron in Alzheimer's disease is due to transferrin desaturation.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Decreased plasma iron in Alzheimer's disease is due to transferrin desaturation.
@en
Decreased plasma iron in Alzheimer's disease is due to transferrin desaturation.
@nl
type
label
Decreased plasma iron in Alzheimer's disease is due to transferrin desaturation.
@en
Decreased plasma iron in Alzheimer's disease is due to transferrin desaturation.
@nl
prefLabel
Decreased plasma iron in Alzheimer's disease is due to transferrin desaturation.
@en
Decreased plasma iron in Alzheimer's disease is due to transferrin desaturation.
@nl
P2093
P50
P356
P1476
Decreased plasma iron in Alzheimer's disease is due to transferrin desaturation.
@en
P2093
Alan Rembach
Christopher J Fowler
Irene Volitakis
Noel G Faux
Robert A Cherny
Rudolf Grimm
P304
P356
10.1021/CN5003557
P577
2015-01-23T00:00:00Z